Showing results (181-190 of 250) with videos related to
Sort By:
Pageof 25
The Journal of Urology|March 1, 1981
The relationship of herpesvirus to carcinoma of the prostateL H Baker, W K Mebust, T D Chin, et al.Cancer|September 15, 1990
A common cytogenetic abnormality and DNA content alterations in dedifferentiated chondrosarcomaM M Zalupski, J F Ensley, J Ryan, et al.Journal of the National Cancer Institute|December 12, 1992
Phase I trial of Taxotere: five-day scheduleR Pazdur, R A Newman, B M Newman, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2019
Analysis of time-to-treatment discontinuation of targeted therapy, immunotherapy, and chemotherapy in clinical trials of patients with non-small-cell lung cancerG M Blumenthal, Y Gong, K Kehl, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
Phase II trial of docetaxel (Taxotere) in metastatic colorectal carcinomaR Pazdur, Y Lassere, L T Soh, et al.Medical Education|September 1, 1978
Measuring clinical competence of medical studentsF F Holmes, L H Baker, E C Torian, et al.Cancer|March 4, 2000
Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group StudyS K Williamson, D Lew, G J Miller, et al.American Journal of Clinical Oncology|August 1, 1993
Phase II trial of merbarone in pancreatic carcinoma. A Southwest Oncology Group studyE H Kraut, T Fleming, J S Macdonald, et al.Cancer|January 15, 1993
Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma. A Southwest Oncology Group studyR M Bukowski, T R Fleming, J S Macdonald, et al.Investigational New Drugs|February 1, 1991
Crisnatol mesylate: phase I dose escalation by extending infusion durationE A Poplin, G G Chabot, R L Tuttle, et al.Pageof 25